Human pancreatic cancer cells expressing mutated BRCA2 lead to hypersensitivity from MMS treatment (Chen et al., 1998) and hsbrca2 mutant embryos are also hypersensitive to γ-irradiation (Sharan et al., 1997). This evidence concerns the gene BRCA2 and pancreatic neoplasm.